Evidence map›Paper›PMID 19478182›Full record

ArticleScience (New York, N.Y.)2009

A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism.

Stéphane Vassilopoulos, Christopher Esk, Sachiko Hoshino, Birgit H Funke, Chih-Ying Chen, Alex M Plocik, Woodring E Wright, Raju Kucherlapati, Frances M Brodsky

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 112 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Membrane trafficking in health and disease.Disease models & mechanisms · 2020
    Review
  19. Article
  20. InducibleThe Journal of biological chemistry · 2019
    Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Stéphane VassilopoulosDepartment of Bioengineering and Therapeutic Sciences, University of California, School of Pharmacy, San Francisco (UCSF), San Francisco, CA 94143, USA.
Christopher Esk
Sachiko Hoshino
Birgit H Funke
Chih-Ying Chen
Alex M Plocik
Woodring E Wright
Raju Kucherlapati
Frances M Brodsky
Harvard University · USThe University of Texas Southwestern Medical Center · USUniversity of California, San Francisco · USUniversity of Tsukuba · JP

Funding

THE MOLECULAR MECHANISM OF CLATHRIN ASSEMBLYR01GM038093 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BRODSKY, FRANCES M. · 1988 to 2014
$5.0M
Comparative Genetics of the DiGeorge Syndrome Gene TBX1R01HD047863 · NICHD · BRIGHAM AND WOMEN'S HOSPITAL · PI KUCHERLAPATI, RAJU S. · 2005 to 2009
$1.5M
NICHD NIH HHS HD47863NICHD NIH HHS R01 HD047863NIGMS NIH HHS GM038093NIGMS NIH HHS R01 GM038093
6 · The paper itself

Abstract

Intracellular trafficking of the glucose transporter GLUT4 from storage compartments to the plasma membrane is triggered in muscle and fat during the body's response to insulin. Clathrin is involved in intracellular trafficking, and in humans, the clathrin heavy-chain isoform CHC22 is highly expressed in skeletal muscle. We found a role for CHC22 in the formation of insulin-responsive GLUT4 compartments in human muscle and adipocytes. CHC22 also associated with expanded GLUT4 compartments in muscle from type 2 diabetic patients. Tissue-specific introduction of CHC22 in mice, which have only a pseudogene for this protein, caused aberrant localization of GLUT4 transport pathway components in their muscle, as well as features of diabetes. Thus, CHC22-dependent membrane trafficking constitutes a species-restricted pathway in human muscle and fat with potential implications for type 2 diabetes.

Indexed as

AdipocytesAnimalsBlood GlucoseCell DifferentiationCell LineCell MembraneClathrinClathrin-Coated VesiclesClathrin Heavy ChainsDiabetes Mellitus, Type 2GlucoseGlucose Transporter Type 4HumansInsulinMiceMice, TransgenicBlood GlucoseClathrinClathrin Heavy ChainsCLTCL1 protein, humanGlucoseGlucose Transporter Type 4InsulinProtein IsoformsSLC2A4 protein, human

Identifiers

PMID19478182
PMCPMC2975026
OpenAlexW1967701730

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.